Comparative Effectiveness of Two Approaches to Diabetes Management in the Uninsured
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
| Condition | Intervention |
|---|---|
|
Diabetes |
Other: nurse-led care management or peer-led self management |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Participant, Outcomes Assessor) Primary Purpose: Health Services Research |
| Official Title: | Comparative Effectiveness of Two Community Based Diabetes Management Approaches |
- hemoglobin A1c [ Time Frame: change from baseline at 6 months for pre-pilot and change from baseline at 6 months and change from baseline at 12 months for pilot ]
| Enrollment: | 64 |
| Study Start Date: | August 2011 |
| Study Completion Date: | April 2015 |
| Primary Completion Date: | April 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Nurse-led care management
Nurse-led care management involves a nurse care manager who performs a comprehensive assessment of the patient then presents those assessment findings to an interdisciplinary team. The team makes care recommendations that are implemented by the care manager in collaboration with the patient's PCP.
|
Other: nurse-led care management or peer-led self management |
|
Experimental: peer-led self managment
Peer-led self management follows the chronic disease self management model where peer counselors lead self management classes for 6 weeks, then conduct monthly support groups
|
Other: nurse-led care management or peer-led self management |
Detailed Description:
The randomized pre-pilot and pilot studies will inform the design of a fully powered trial that will test the effectiveness of a nurse-led interdisciplinary care management intervention (CM) for improving hemoglobin A1c in uninsured diabetic patients who receive their primary medical care from a community-based free clinic compared to similar patients who undergo peer-led self management (SM). The comparative effectiveness of these approaches has not been tested in a randomized trial.
To ensure the success of the pilot study the investigators will perform a 6 month pre-pilot study using 10 patients per group. This pre-pilot will be used to establish protocols covering enrollment, HIPAA, consent, interventions and outcome measurement. The subsequent 1 year pilot will be used to demonstrate feasibility, estimate recruitment, attendance and follow up, refine inclusion criteria, provide power analysis, optimize the interventions and determine appropriate secondary outcomes for a fully powered trial. For the pilot, thirty patients will be randomized to the CM intervention for the first 6 months. Major components of the nurse-led CM model include: 1) assessment and goal setting for self-management; 2) education for self efficacy and productive clinical encounters; 3) access to specialist care via an interdisciplinary team; 4) evidence-based treatment recommendations responsive to patients' goals; and 5) care coordination by a nurse care manager. From 6-12 months patients will return to usual clinic care.
The 30 patients randomized to the SM group will be invited to attend weekly peer-led SM training broadly based on the Stanford University Diabetes Self-management Program's Train the Trainer Model. The training will occur over 6 weeks and will cover topics common to most chronic disease SM programs including: goal setting, self-management of chronic conditions, making action plans, feedback and problem solving, handling emotions, symptom management techniques, communication with health care providers, medications and making treatment decisions. The peer advisors and a nurse will then lead 1 hour monthly group sessions for the remainder of the first 6 months for review/revision of action plans, review of self management techniques and ongoing social persuasion and modeling. From 6-12 months patients will return to usual clinic care.
For the pilot, outcome measures will be obtained at 6 and 12 months. For this pilot, the investigators will not test any hypotheses. Instead, effect sizes and confidence intervals will be calculated for each outcome. These results will be used for power analysis. The results will also allow us to see which interventions are most effective on which outcomes and allow us to optimize the interventions to have the greatest impact on the primary outcome, hemoglobin A1c. Cost effectiveness will be determined in a fully powered trial.
Eligibility| Ages Eligible for Study: | 25 Years to 75 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients will be eligible if they are between the ages of 25 and 75,
- have a diagnosis of diabetes (type II) with a hemoglobin A1c >[7.0] There will be no exclusions based on gender, race or ethnicity.
Exclusion Criteria:
- have no other illness that would dominate their care (e.g., terminal cancer, numerous exacerbations of CHF), and
- are not pregnant.
- patients must have no cognitive impairment.
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT01653951
| Principal Investigator: | Edward D Scott, MD | Summa Health System |
More Information
| Responsible Party: | Edward Scott, Physician, Summa Health System |
| ClinicalTrials.gov Identifier: | NCT01653951 History of Changes |
| Other Study ID Numbers: |
shs250014 1R03DK090351-01 ( US NIH Grant/Contract Award Number ) |
| Study First Received: | July 20, 2012 |
| Last Updated: | July 16, 2015 |
Additional relevant MeSH terms:
|
Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on May 25, 2017